of this particular antiviral is obviously very good news. the company, when they briefed us last night, had mentioned that they will be submitting their data to the fda imminently. the data are impressive. pills were given to 775 elderly or medically at—risk patients within five days of them showing coronavirus symptoms. the data from a phase three trial showed 7.3% of patients on the drug were hospitalised, compared to 14.1% of those who did not take the tablets. eight patients who were given a placebo — or dummy pill — later died of covid, but there were no deaths in the group taking the pill. the trial was stopped early because the pill was so successful. the data still needs to be peer—reviewed. so how does it work? as coronavirus replicates itself inside your body,